Floatz logo

Probenecid

Drug Dependence of Morphine Type

University of CalgarySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Drug Dependence of Morphine Type cohort.

Asset / SponsorPhaseRating
Bxcl501
National Taiwan University Hospital
N/ANR

Same molecule, other indications

Probenecid is also rated in:

cytomegalovirus retinitisDormant
BB
Indicative ·
69 / 100
View asset →
HIV infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →
impaired renal function diseaseDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →